IRIS UniCatt

Paris, Ida
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.278
EU - Europa 897
AS - Asia 599
SA - Sud America 115
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 2.918
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.254
SE - Svezia 249
SG - Singapore 232
IT - Italia 185
CN - Cina 144
DE - Germania 130
BR - Brasile 105
IN - India 79
FR - Francia 73
IE - Irlanda 64
GB - Regno Unito 46
ID - Indonesia 40
FI - Finlandia 36
RU - Federazione Russa 23
HK - Hong Kong 19
PH - Filippine 19
KR - Corea 18
CA - Canada 17
BE - Belgio 15
CI - Costa d'Avorio 13
ES - Italia 13
UA - Ucraina 13
TR - Turchia 12
AT - Austria 11
IR - Iran 9
PL - Polonia 8
NL - Olanda 6
VN - Vietnam 6
RO - Romania 5
BD - Bangladesh 4
BZ - Belize 4
EU - Europa 4
AR - Argentina 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
MX - Messico 3
PK - Pakistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
HU - Ungheria 2
KZ - Kazakistan 2
MA - Marocco 2
NO - Norvegia 2
PE - Perù 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
TN - Tunisia 1
Totale 2.918
Salva come PNG Salva come JPEG
Città #
Chandler 289
Singapore 160
Ashburn 107
Hyderabad 65
Dublin 64
New York 59
Jakarta 40
Rome 38
The Dalles 38
Chicago 35
San Mateo 32
Ann Arbor 29
Milan 29
Bremen 27
Los Angeles 27
Princeton 27
Wilmington 27
Munich 26
Boston 25
Fairfield 24
Helsinki 21
Marseille 18
Hefei 17
Hong Kong 17
Seoul 17
Frankfurt am Main 16
Jacksonville 15
Brussels 14
Moscow 14
Nanjing 14
Nuremberg 14
Abidjan 13
Buffalo 12
London 12
Seattle 12
Salt Lake City 11
Beijing 10
Boardman 10
Lancaster 10
Lauterbourg 10
São Paulo 10
Augusta 9
Cattolica 9
Düsseldorf 9
Izmir 9
Turku 9
North Bergen 8
Council Bluffs 7
Florence 7
Tampa 7
Andover 6
Dearborn 6
Elk Grove Village 6
Kunming 6
Portsmouth 6
San Diego 6
Warsaw 6
Woodbridge 6
Belo Horizonte 5
Guangzhou 5
Nanchang 5
Paris 5
Pasig 5
Quezon City 5
Redwood City 5
Shenyang 5
Sterling 5
Toronto 5
Vienna 5
Belize City 4
Cambridge 4
Clearwater 4
Dulles 4
Goiânia 4
Hebei 4
Leawood 4
Montepulciano 4
Naples 4
Shenzhen 4
Bari 3
Drobeta-Turnu Severin 3
Hangzhou 3
Kansas City 3
Kish 3
Lappeenranta 3
Laval 3
Madrid 3
Majadahonda 3
Norwalk 3
Ottawa 3
Padova 3
Redmond 3
Sacramento 3
Santa Clara 3
Tianjin 3
Almaty 2
Amsterdam 2
Bacoor 2
Barbacena 2
Barcelona 2
Totale 1.730
Salva come PNG Salva come JPEG
Nome #
Neoadjuvant chemotherapy in breast cancer: An advanced personalized multidisciplinary prehabilitation model (apmp-m) to optimize outcomes 231
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 143
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 128
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 107
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 93
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 92
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 92
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 92
Techniques for sentinel node biopsy in breast cancer 88
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach 80
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 77
Ovarian reserve after chemotherapy in breast cancer: A systematic review and meta-analysis 77
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 76
Breast cancer drug approvals issued by EMA: A review of clinical trials 72
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 71
Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals 70
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 70
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach 69
Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome 68
Palliative electrochemotherapy in primary or recurrent vulvar cancer 68
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer 67
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 66
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 65
Oligometastatic Breast Cancer: How to Manage It? 63
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 61
Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer 60
Impact of scalp cooling device (SCD) in preventing alopecia in women undergoing chemotherapy for breast cancer 60
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 56
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 56
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes 56
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2 52
Spectrum of germline BRCA1 and BRCA2 variants identified in 2351 ovarian and breast cancer patients referring to a reference cancer hospital of Rome 52
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis 52
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents 45
Ultrasound morphometric and cytologic preoperative assessment of inguinal lymph-node status in women with vulvar cancer: MorphoNode study 45
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 42
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 39
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy 38
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 37
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives 34
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine 18
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria 16
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 15
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study 10
Baseline 18F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters 9
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors 6
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 3
Totale 2.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 0 0 0 0 12 3
2020/202188 9 2 5 9 10 2 9 2 8 8 17 7
2021/2022377 25 19 10 27 11 28 15 51 20 21 80 70
2022/2023782 95 105 67 130 30 105 46 60 96 14 17 17
2023/2024469 15 95 19 30 22 75 52 24 12 23 44 58
2024/20251.121 22 21 106 39 95 52 41 49 130 197 369 0
Totale 2.987